Belgium· BE-AMP-SAM340453-00
Indium (111In) Oxinate Curium 37 MBq/ml
A 111in-indium-oxinat markierte zellen product containing indium (111 in) oxine, registered in Belgium by Curium Belgium. The same ATC class is registered in 5 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
111in-indium-oxinat markierte zellen is registered in 5 of 19 countries.
Countries holding a registration under ATC V09HB01 (111in-indium-oxinat markierte zellen), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 3 of them publish a price we can compare per daily dose
111in-indium-oxinat markierte zellen · ATC V09HB01
5 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Netherlands
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Indium (111 In) Oxine
- Manufacturer
- Curium Belgium
- Country
- Belgium (BE)
- ATC code
- V09HB01
- ATC class
- 111In-Indium-oxinat markierte Zellen
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 1
- be_apb3336005
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under V09HB01
111in-indium-oxinat markierte zellen, as other registers publish it.
- NetherlandsIndium (In 111) Oxinate, radiofarmaceutische uitgangsoplossing 37 MBq/mlCurium Netherlands B.V.
- DenmarkIndium (In111) OxinateCurium Netherlands B.V.
- CzechiaINDIUM (IN111) OXINATECurium Netherlands B.V., Petten
- FinlandIndium In-111 OxinateCurium Netherlands B.V.
- FinlandIndium-In-111 OxineGE Healthcare Limited
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/a1d521cd-753a-4646-9c70-5dde3849c13f GET /v1/drugs/a1d521cd-753a-4646-9c70-5dde3849c13f?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Radiopharmaceutical precursor",
"source": "afmps",
"status": "AUTHORIZED",
"name_en": "Indium (111In) Oxinate Curium 37 MBq/ml",
"name_fr": "Indium (111In) Oxinate Curium 37 MBq/ml",
"name_nl": "Indium (111In) Oxinate Curium 37 MBq/ml",
"amp_code": "SAM340453-00",
"strengths": [
"37.0000",
"37.0000",
"0.0250",
"0.0250",
"3.4000",
"5.9000"
],
"pack_count": 1,
"substances": [
"Indium (111 In) Oxine",
"Hydroxyquinoline",
"Sodium Acetate Trihydrate",
"Sodium Chloride"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Indium (111in) Oxinate Labelled Cells",
"authorisation_numbers": [
"BE340453"
]
}See everything about 111in-indium-oxinat markierte zellen.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.